» Articles » PMID: 24555089

Thousands of Exon Skipping Events Differentiate Among Splicing Patterns in Sixteen Human Tissues

Overview
Journal F1000Res
Date 2014 Feb 25
PMID 24555089
Citations 263
Authors
Affiliations
Soon will be listed here.
Abstract

Alternative splicing is widely recognized for its roles in regulating genes and creating gene diversity. However, despite many efforts, the repertoire of gene splicing variation is still incompletely characterized, even in humans. Here we describe a new computational system, ASprofile, and its application to RNA-seq data from Illumina's Human Body Map project (>2.5 billion reads).  Using the system, we identified putative alternative splicing events in 16 different human tissues, which provide a dynamic picture of splicing variation across the tissues. We detected 26,989 potential exon skipping events representing differences in splicing patterns among the tissues. A large proportion of the events (>60%) were novel, involving new exons (~3000), new introns (~16000), or both. When tracing these events across the sixteen tissues, only a small number (4-7%) appeared to be differentially expressed ('switched') between two tissues, while 30-45% showed little variation, and the remaining 50-65% were not present in one or both tissues compared.  Novel exon skipping events appeared to be slightly less variable than known events, but were more tissue-specific. Our study represents the first effort to build a comprehensive catalog of alternative splicing in normal human tissues from RNA-seq data, while providing insights into the role of alternative splicing in shaping tissue transcriptome differences. The catalog of events and the ASprofile software are freely available from the Zenodo repository ( http://zenodo.org/record/7068; doi: 10.5281/zenodo.7068) and from our web site http://ccb.jhu.edu/software/ASprofile.

Citing Articles

Fine-tuning of Wnt signaling by RNA surveillance factor Smg5 in the mouse craniofacial development.

Zhu S, Huo S, He W, Huang C, Zhang J, Jiang X iScience. 2025; 28(3):111972.

PMID: 40071146 PMC: 11894330. DOI: 10.1016/j.isci.2025.111972.


NONO regulates mC modification and alternative splicing of PTEN mRNAs to drive gastric cancer progression.

Zhao G, Liu R, Ge L, Qi D, Wu Q, Lin Z J Exp Clin Cancer Res. 2025; 44(1):81.

PMID: 40033337 PMC: 11877715. DOI: 10.1186/s13046-024-03260-z.


Weighted Gene Correlation Network Analysis Reveals Key Regulatory Genes Influencing Selenium Enrichment and Yield with Exogenous Selenite in Tartary Buckwheat.

Ye X, Mei L, Gan Z, Wang Z, Sun W, Fan Y Plants (Basel). 2025; 14(3).

PMID: 39942985 PMC: 11820427. DOI: 10.3390/plants14030423.


Integrated Transcriptomics and Metabolomics Analysis Reveals Convergent and Divergent Key Molecular Networks of Dominant Genic Male Sterility and Cytoplasmic Male Sterility in Cabbage.

Zhang N, Kuang L, Yang L, Wang Y, Han F, Zhang Y Int J Mol Sci. 2025; 26(3).

PMID: 39941029 PMC: 11818720. DOI: 10.3390/ijms26031259.


Comparative transcriptome profiling reveals the mechanism of increasing lysine and tryptophan content through pyramiding , and genes in maize.

Wu P, Yuan Y, Ma Z, Zhang K, Deng L, Ren H Breed Sci. 2025; 74(4):311-323.

PMID: 39872326 PMC: 11769590. DOI: 10.1270/jsbbs.23051.


References
1.
Richard H, Schulz M, Sultan M, Nurnberger A, Schrinner S, Balzereit D . Prediction of alternative isoforms from exon expression levels in RNA-Seq experiments. Nucleic Acids Res. 2010; 38(10):e112. PMC: 2879520. DOI: 10.1093/nar/gkq041. View

2.
Florea L, Di Francesco V, Miller J, Turner R, Yao A, Harris M . Gene and alternative splicing annotation with AIR. Genome Res. 2005; 15(1):54-66. PMC: 540277. DOI: 10.1101/gr.2889405. View

3.
Garcia-Blanco M, Baraniak A, Lasda E . Alternative splicing in disease and therapy. Nat Biotechnol. 2004; 22(5):535-46. DOI: 10.1038/nbt964. View

4.
Pruitt K, Harrow J, Harte R, Wallin C, Diekhans M, Maglott D . The consensus coding sequence (CCDS) project: Identifying a common protein-coding gene set for the human and mouse genomes. Genome Res. 2009; 19(7):1316-23. PMC: 2704439. DOI: 10.1101/gr.080531.108. View

5.
Narla G, DiFeo A, Yao S, Banno A, Hod E, Reeves H . Targeted inhibition of the KLF6 splice variant, KLF6 SV1, suppresses prostate cancer cell growth and spread. Cancer Res. 2005; 65(13):5761-8. DOI: 10.1158/0008-5472.CAN-05-0217. View